NASDAQ:HEXOHEXO Stock Price, Forecast & News Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding HEXO Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add $0.74 0.00 (-0.18 %) (As of 07/2/2020 12:43 PM ET) Add Compare Share Today's Range$0.72Now: $0.74▼$0.7550-Day Range$0.44MA: $0.73▼$1.1952-Week Range$0.35Now: $0.74▼$5.38Volume172,365 shsAverage Volume11.70 million shsMarket Capitalization$317.69 millionP/E RatioN/ADividend YieldN/ABetaN/A ProfileAnalyst RatingsAdvanced ChartCompetitorsEarningsInstitutional OwnershipHeadlinesOptions ChainSocial Media HEXO Corp., through its subsidiary, HEXO Operations Inc., produces, markets, and sells cannabis in Canada. The company offers dried cannabis under the Time of Day and H2 lines; Elixir, a cannabis oil sublingual mist product line; and Decarb, an activated fine-milled cannabis powder product. It provides its products under the HEXO and Hydropothecary brand names. The company serves medical and adult-use markets. The company was formerly known as The Hydropothecary Corporation and changed its name to HEXO Corp. in August 2018. HEXO Corp. is headquartered in Gatineau, Canada.Read More Beat the Market (BTM) Rank™ 3.8 Analyst's Opinion Consensus RatingHEXO has received a consensus rating of Hold. The company's average rating score is 1.53, and is based on 1 buy rating, 8 hold ratings, and 10 sell ratings.Price Target Upside/DownsideAccording to analysts' consensus price target of $1.66, HEXO has a potential upside of 124.3% from its current price of $0.74.Amount of Analyst CoverageHEXO has been the subject of 6 research reports in the past 90 days, demonstrating strong analyst interest in this stock. Previous Next 2.4 Community Rank Outperform VotesHEXO has received 116 “outperform” votes. (Add your “outperform” vote.)Underperform VotesHEXO has received 128 “underperform” votes. (Add your “underperform” vote.)Community SentimentHEXO has received 52.46% “underperform” votes from our community.MarketBeat's community ratings are surveys of what our community members think about HEXO and other stocks. Vote “Outperform” if you believe HEXO will outperform the S&P 500 over the long term. Vote “Underperform” if you believe HEXO will underperform the S&P 500 over the long term. You may vote once every thirty days. Previous Next 0.0 Dividend Strength Dividend YieldHEXO does not currently pay a dividend.Dividend GrowthHEXO does not have a long track record of dividend growth. Previous Next 0.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, HEXO insiders have not sold or bought any company stock. Previous Next 0.0 Earnings and Valuation Previous Next Analyst Opinion: 3.8Community Rank: 2.4Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -Overall Beat the Market Rank™1.23 out of 5 stars Industry, Sector and Symbol Stock Exchange NASDAQ Industry Drug Manufacturers - Specialty & Generic Sub-IndustryN/A SectorMedical Current SymbolNASDAQ:HEXO Previous Symbol CUSIPN/A CIKN/A Webhexo.com Phone844-406-1852Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/APrice-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AProfitability EPS (Most Recent Fiscal Year)N/A Net IncomeN/A Net MarginsN/A Return on EquityN/A Return on AssetsN/AMiscellaneous EmployeesN/A Outstanding Shares430,073,000Market Cap$317.69 million Next Earnings Date10/26/2020 (Estimated) OptionableOptionable NASDAQ:HEXO Rates by TradingView Receive HEXO News and Ratings via Email Sign-up to receive the latest news and ratings for HEXO and its competitors with MarketBeat's FREE daily newsletter. HEXO (NASDAQ:HEXO) Frequently Asked Questions How has HEXO's stock been impacted by COVID-19 (Coronavirus)? HEXO's stock was trading at $0.9376 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, HEXO shares have decreased by 21.1% and is now trading at $0.7399. View which stocks have been most impacted by Coronavirus. Do Wall Street analysts recommend investors buy shares of HEXO? 19 Wall Street analysts have issued "buy," "hold," and "sell" ratings for HEXO in the last year. There are currently 10 sell ratings, 8 hold ratings and 1 buy rating for the stock, resulting in a consensus recommendation of "Hold." View analyst ratings for HEXO. When is HEXO's next earnings date? HEXO is scheduled to release its next quarterly earnings announcement on Monday, October 26th 2020. View our earnings forecast for HEXO. How were HEXO's earnings last quarter? HEXO Corp. (NASDAQ:HEXO) posted its earnings results on Thursday, June, 11th. The company reported ($0.07) earnings per share for the quarter, missing the Thomson Reuters' consensus estimate of ($0.05) by $0.02. The company had revenue of $22.48 million for the quarter, compared to analysts' expectations of $14.19 million. View HEXO's earnings history. What price target have analysts set for HEXO? 19 Wall Street analysts have issued 12-month target prices for HEXO's shares. Their forecasts range from $1.00 to $4.00. On average, they expect HEXO's stock price to reach $1.66 in the next year. This suggests a possible upside of 124.3% from the stock's current price. View analysts' price targets for HEXO. Has HEXO been receiving favorable news coverage? News coverage about HEXO stock has trended very negative recently, according to InfoTrie Sentiment Analysis. The research firm scores the sentiment of media coverage by analyzing more than six thousand blog and news sources in real-time. The firm ranks coverage of companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. HEXO earned a coverage optimism score of -3.3 on InfoTrie's scale. They also gave media coverage about the company a news buzz of 0.0 out of 10, meaning that recent media coverage is extremely unlikely to have an effect on the stock's share price in the near future. View the latest news about HEXO. Who are some of HEXO's key competitors? Some companies that are related to HEXO include Knight Therapeutics (GUD), Ecofibre (EOF), HLS Therapeutics (HLS), OrganiGram (OGI), Next Science (NXS), Amryt Pharma (AMYT), ICC Labs (ICC), Benchmark (BMK), ESSA Pharma (EPI), Probiotec (PBP), Green Organic Dutchman (TGOD), Shield Therapeutics (STX), WeedMD (WMD), Althea Group (AGH) and Supreme Cannabis (FIRE). View all competitors. What other stocks do shareholders of HEXO own? Based on aggregate information from My MarketBeat watchlists, some companies that other HEXO investors own include Aurora Cannabis (ACB), Canopy Growth (CGC), Cronos Group (CRON), Aphria (APHA), OrganiGram (OGI), Aurora Cannabis (ACB), Tilray (TLRY), Charlotte's Web (CWBHF), NVIDIA (NVDA) and Alibaba Group (BABA). Who are HEXO's key executives? HEXO's management team includes the following people: Mr. Sebastien G. St-Louis, Co-Founder, Pres, CEO & Director (Age 35)Mr. Adam Miron, Co-founder, Chief Brand Officer & Director (Age 35)Mr. Ed Chaplin, CFO & Corp. Sec. (Age 49)Mr. James McMillan, VP of Bus. Devel. (Age 51)Dr. Terence Lake DVM, Vice-Pres of Corp. & Social Responsibility What is HEXO's stock symbol? HEXO trades on the NASDAQ under the ticker symbol "HEXO." How do I buy shares of HEXO? Shares of HEXO can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. What is HEXO's stock price today? One share of HEXO stock can currently be purchased for approximately $0.74. How big of a company is HEXO? HEXO has a market capitalization of $318.21 million. What is HEXO's official website? The official website for HEXO is hexo.com. How can I contact HEXO? The company can be reached via phone at 844-406-1852. This page was last updated on 7/2/2020 by MarketBeat.com Staff 30 Days of MarketBeat All Access for $1.00 Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your Risk-Free Trial Subscription Here Questions? Get Started with MarketBeat — Read Your Daily NewsletterCheck Out My MarketBeatWatch Our Tutorial VideosAdd a Stock to Your WatchlistSet Up an Instant AlertView a Company's Profile PageView Our Financial CalendarsView Today's Analyst Ratings
